Hypouricemic effect and safety of febuxostat used for prevention of tumor lysis syndrome.
about
Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol.Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency.Toward an Understanding of Structural Insights of Xanthine and Aldehyde Oxidases: An Overview of their Inhibitors and Role in Various Diseases.Managing Tumor Lysis Syndrome in the Era of Novel Cancer Therapies
P2860
Hypouricemic effect and safety of febuxostat used for prevention of tumor lysis syndrome.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Hypouricemic effect and safety of febuxostat used for prevention of tumor lysis syndrome.
@en
Hypouricemic effect and safety of febuxostat used for prevention of tumor lysis syndrome.
@nl
type
label
Hypouricemic effect and safety of febuxostat used for prevention of tumor lysis syndrome.
@en
Hypouricemic effect and safety of febuxostat used for prevention of tumor lysis syndrome.
@nl
prefLabel
Hypouricemic effect and safety of febuxostat used for prevention of tumor lysis syndrome.
@en
Hypouricemic effect and safety of febuxostat used for prevention of tumor lysis syndrome.
@nl
P2093
P2860
P356
P1433
P1476
Hypouricemic effect and safety of febuxostat used for prevention of tumor lysis syndrome.
@en
P2093
Hideto Minohara
Koichiro Maie
Masato Homma
Naoki Kurita
Shigeru Chiba
Shintaro Yanagimoto
Yasuhisa Yokoyama
Yuichi Hasegawa
P2860
P2888
P356
10.1186/2193-1801-3-501
P577
2014-09-05T00:00:00Z
P5875
P6179
1042700701